Compare LQDA & CVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LQDA | CVBF |
|---|---|---|
| Founded | 2004 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2020 | 2009 |
| Metric | LQDA | CVBF |
|---|---|---|
| Price | $63.23 | $20.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $41.00 | $24.50 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.95% |
| EPS Growth | ★ 51.81 | 5.56 |
| EPS | ★ 0.52 | 0.38 |
| Revenue | ★ $158,320,000.00 | N/A |
| Revenue This Year | $278.87 | $21.47 |
| Revenue Next Year | $57.13 | $15.21 |
| P/E Ratio | $107.10 | ★ $52.32 |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $11.85 | $17.95 |
| 52 Week High | $63.46 | $21.48 |
| Indicator | LQDA | CVBF |
|---|---|---|
| Relative Strength Index (RSI) | 67.44 | 53.73 |
| Support Level | $30.48 | $19.84 |
| Resistance Level | $63.46 | $20.85 |
| Average True Range (ATR) | 3.55 | 0.40 |
| MACD | -0.68 | -0.00 |
| Stochastic Oscillator | 74.24 | 69.39 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit. It is a community bank with one reportable operating segment.